The potential use of the pregnane X receptor in cardiovascular therapy

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

The authors wish to thank the British Heart Foundation (BS/02/002), the Wellcome Trust (074361/Z/04/Z) and Barts and the London Charitable Trust (non-clinical research fellowship 427/438) for their support of research contributing to this editorial. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.